AMSA PharmFree Fellow Reshma Ramachandran joined a panel on
American Law Journal to debate whether physicians should take money from pharmaceutical companies. They also discussed the recent GlaxoSmithKline settlement over "unsavory marketing practices" and its "unhealthy alliance with doctors," specifically Dr. Drew.